Literature DB >> 7015218

Ocular cicatricial pemphigoid.

B J Mondino, S I Brown.   

Abstract

The characteristic feature of ocular cicatricial pemphigoid (OCP) is progressive shrinkage of the conjunctiva. In our series of 78 patients with OCP, 21% had cutaneous involvement and 50% had involvement of the oral mucosa. Immunoglobulins and the third component of complement are found bound to the conjuctival epithelium and basement membrane of patients with OCP. Circulating antibodies which bind to the conjunctival and corneal epithelium but not to the conjunctival basement membrane have also been demonstrated. OCP is associated with an increased prevalence of HLA-B12. The lids and conjunctiva of patients with OCP demonstrate an increased incidence of potential pathogens when compared with age- and sex-matched controls. When followed for a period averaging 22 months, the majority of patients not treated with systemic immunosuppressives or topical corticosteroids progress. However, OCP has a variable course because there were patients in all stages who did not progress. The acute manifestations of OCP may cause rapid shrinkage of the conjunctiva and may be suppressed systemic corticosteroids.

Entities:  

Mesh:

Year:  1981        PMID: 7015218     DOI: 10.1016/s0161-6420(81)35069-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  35 in total

Review 1.  Autoimmune bullous diseases: ocular manifestations and management.

Authors:  Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid.

Authors:  Valerie P J Saw; Enno Schmidt; Ifeoma Offiah; Grazyna Galatowicz; Detlef Zillikens; John K G Dart; Virginia L Calder; Julie T Daniels
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  The evil curse of ocular pemphigoid.

Authors:  P Hossain
Journal:  Eye (Lond)       Date:  2011-09       Impact factor: 3.775

4.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

5.  Cicatricial pemphigoid.

Authors:  C S Foster
Journal:  Trans Am Ophthalmol Soc       Date:  1986

6.  Cryotherapy for trichiasis in ocular cicatricial pemphigoid.

Authors:  M J Elder; W Bernauer
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

Review 7.  Severity score indexes for blistering diseases.

Authors:  Benjamin S Daniel; Michael Hertl; Victoria P Werth; Rüdiger Eming; Dédée F Murrell
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

8.  Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.

Authors:  Sarah D Ahadome; David J Abraham; Suryanarayana Rayapureddi; Valerie P Saw; Daniel R Saban; Virginia L Calder; Jill T Norman; Markella Ponticos; Julie T Daniels; John K Dart
Journal:  JCI Insight       Date:  2016-08-04

9.  Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.

Authors:  M J Elder; S Lightman; J K Dart
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

10.  Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid.

Authors:  A R Ahmed; S Foster; M Zaltas; G Notani; Z Awdeh; C A Alper; E J Yunis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.